Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Leaders Committed to Antibiotic Stewardship

Antibiotic stewardship is the development, promotion, and implementation of activities to ensure the appropriate use of antibiotics. By  adopting antibiotic stewardship principles, organizations can improve how antibiotics are used and prescribed, and can slow the rise of antibiotic resistant infections.

Is your organization involved in stewardship activities or interested in making a commitment like these leaders? Use the instructions below and consider submitting a letter of commitment to

Click to learn how to make a commitment to stewardship today

Leaders in health are invited to submit a description (or letter of commitment) of their organization’s commitment to actively promote and implement principles of good antibiotic stewardship, and specific actions the organization plans to take to advance antibiotic stewardship objectives in the National Strategy for Combating Antibiotic-Resistant Bacteria [PDF – 37 pages] and the five-year National Action Plan for Combating Antibiotic-Resistant Bacteria [PDF – 63 pages].

Commitment letters should be drafted on your organization’s letterhead and emailed to Commitment letters should include the following information:

  1. Name of organization and point of contact’s information (i.e., name, title, phone number, email address).
  2. A description of your organization’s commitment to promote and implement principles of good antibiotic stewardship. The description should include the type of activities for implementation by your organization (i.e., antimicrobial use and resistance reporting, implementing stewardship programs and evidence-based guidelines, diagnostics development, implementation, Get Smart education) and specific actions your organization will take over the next five years to advance specific antibiotic stewardship objectives under Goal 1 of the National Strategy for Combating Antibiotic-Resistant Bacteria [PDF – 37 pages]. Descriptions should also include targets, milestones, or accomplishments to benchmark your stewardship success.
  3. Language indicating if CDC can summarize your organization’s commitments, share the summaries online, and make your commitment letter available on request. See the List of Commitment Letters below for summaries of stewardship commitments already received. After your organization’s commitment letter is received, you will be contacted for additional information about antibiotic stewardship implementation activities.

The summary of stewardship commitments found below are activities submitted to CDC that are being implemented by leaders in the U.S.  Select a category below to view each organization’s commitment and key activities.

List of Commitments

A - AL

  • AARP will provide information to its members to help them have informed conversations with their health care providers about the appropriate use of antibiotics and their increased risk for Clostridium difficile infection, and help inform people about the importance of taking antibiotics only when needed and as directed.

  • Abbott/Ibis Biosciences will work with the FDA to bring technology like IRIDICA, a new molecular testing platform, to the U.S., and is focused on developing complementary testing innovations to help improve appropriate antibiotic usage. Abbott is currently committed to:

  • ABIM Foundation (Choosing Wisely with Consumer Reports) is committed to operating a grant program in which more than 20 participating health systems, hospitals and medical groups will work toward a goal of reducing their utilization of antibiotics to treat viral infections in adults. Interventions may include clinical decision support, data/feedback, academic detailing and community, patient and physician education. The ABIM Foundation is also committed to continuing to operate Choosing Wisely, in which participating medical specialty societies recommend tests and treatments within their specialty that are overused.

  • Accelerate Diagnostics will sponsor studies on the role of rapid diagnostics and early antimicrobial de-escalation in hospitals, plus pursue the development and regulatory clearance of rapid diagnostic tests.
  • Accreditation Council for Graduate Medical Education will identify and disseminate targeted antibiotic stewardship information to faculty, residents, and fellows, reaching over 122,000 residents and fellows in over 9,500 programs in pediatrics, internal medicine, family medicine, surgery and more.
  • Allergan will support: greater sharing of surveillance data generate by the company that specifically look at resistance prevalence phenotypically (national, regional, and hospital unit-specific data); generation of real-world outcomes data to highlight the effect of stewardship on outcomes; and establishment of collaborative research networks/centers of excellence to bring greater awareness of resistance prevalence and burden of illness.
  • AdvaMedDX will develop educational materials on the role of diagnostic tests in fighting antibiotic resistance, develop collaborative efforts to disseminate aforementioned educational materials to hospitals, clinicians, and public health professionals, and organize a Capitol Hill briefing to educate policy makers on how diagnostic tests fight antibiotic resistance. See the White House press release for additional information [PDF – 10 pages].
  • Advancing Excellence in Long-Term Care Collaborative will help translate the tools and resources to support efforts to reduce unnecessary antibiotic use and promote better antibiotic stewardship.  In addition, the Advancing Excellence in American’s Nursing Homes Campaign’s (AE) website ( is the repository of resources and clinical tools featuring nine organization and clinical goals, including an infection prevention goal focused on reducing C. difficile infections, to assist nursing homes in improving the quality of life and quality of care of residents.
  • Alere will highlight the critical role that diagnostics play in effective antibiotic stewardship; publicly release educational materials on the use of rapid diagnostics in antimicrobial stewardship, including Continuing Medical Education accredited webinars; and complete a study on the acceptability, feasibility, barriers and challenges to use of specific, new, point of care tests in United States primary care settings.
  • ALK-Abello will educate medical professionals and patients on the prevalence of inaccurate penicillin allergies, the downsides of using alternative antibiotics, and their role in bacterial infection and drug resistance; collaborate with industry leaders to improve antibiotic prescribing and help prevent the spread of resistant bacteria by encouraging penicillin allergy evaluation prior to use of alternatives; strengthen antibiotic stewardship through reduction in overprescribed alternatives; and continuously fund research on how inappropriate antibiotic use impacts patient treatment, antibiotic resistance, and healthcare economics.
  • Alliance for Aging Research will create and distribute health education materials for seniors and family caregivers on antibiotic misuse and resistance, as well as the value of stewardship, in clinical and long-term care settings with a downloadable fact sheet and a “pocket film;” elevate the issue of antibiotic misuse and resistance, as well as the value of stewardship, within the aging social service and provider community; and continue to expand work on healthcare-associated infections (HAIs) by launching a public policy effort to require long-term care setting reporting of HAIs to the CDC, and to initiate stewardship programs to help reduce the incidence of HAIs.
  • Alliance for the Prudent Use of Antibiotics (APUA) will continue to work with CDC and WHO to compile and disseminate information on resistance and model interventions to combat the antibiotic resistance problem; customize its APUA Newsletter with a “Prudent Antibiotic Use“ component focused on stewardship challenges and opportunities and tailored to specific goals in the Action Plan and to the needs of the participating agencies; tap into its network of APUA opinion leaders to develop webinars related to various aspects of the proposed stewardship plan; propose a national PCP survey and physician education campaign to explore the challenges involved in appropriate antibiotic prescribing and attitudes concerning the potential for rapid point of care diagnostics in improving antibiotic use; and work with agencies to establish a pilot interventions network.


  • AMDA – The Society for Post-Acute and Long-Term Care Medicine will develop and deploy a training course for long-term care practitioners that include antibiotic stewardship and develop a quality prescribing campaign for medication safety that include a focus on antibiotic stewardship.
  • America’s Essential Hospitals will share all related materials from the administration and CDC with its membership; participate in national summits, workgroups, or roundtables; engage members as health care leaders to share best practices and learn from each other; nominate members to serve on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria; and participate in additional activities or projects at the request of the administration or CDC.

  • American Academy of Emergency Medicine will assist with clinical practice guideline development for antibiotic use in emergency departments, development of position statements covering best practices in emergency care antibiotic stewardship, and development of emergency-department antibiotic use quality measures.
  • American Academy of Family Physicians will take a leadership role in advocating for appropriate use of antibiotics by partnering with organizations, like the CDC’s Get Smart program in their national efforts to curb inappropriate antibiotic use; educate family physicians and patients on the importance of appropriate antibiotic use; and seek funding opportunities to identify best practices for appropriate antibiotic prescribing in practice-based settings.  

  • American Academy of Pediatrics will dedicate an entire chapter to antimicrobial stewardship in the newly revised 2015 Red Book, publish articles and technical and promote educational efforts for physicians that amplify the messages from recent clinical guidelines and assist with communication about appropriate antibiotic use to patients and families.
  • American Academy of Physicians Assistants will continue its long-standing commitment to antibiotic stewardship by continuing to employ a multi-pronged approach to advancing the issue through policy, education, and collaboration through activities like formulating and adopting numerous policies on the issue, including provider and patient education regarding antimicrobial resistance and prudent use of antibiotics; featuring antimicrobial resistance and antibiotic stewardship in its live and online continuing medical education programs; partnering with the Infectious Diseases Society of America’s (IDSA) Stakeholder Forum on Antimicrobial Resistance (S-FAR); and actively engaging with the Get Smart: Know When Antibiotics Work program.

  • American Association of Nurse Practitioners will promote awareness of the Antibiotic Stewardship Initiative to members on its website and through electronic newsletters and bulletins; share materials with members on how they can engage in antibiotic stewardship in their practices; and provide continuing education to members through presentations at annual conferences and in the Continuing Education Center.
  • American College of Physicians (ACP) will commit its participation at the National Forum on Antibiotic Stewardship. ACP education programs, products, and services reach over 200,000 providers annually.  ACP has the ability to disseminate resources on topics important to internal medicine, such as appropriate antibiotic use, through multiple educational channels which have an impact on patient care. Example include clinical information and educational resources, conferences and meetings, practice and quality improvement resources, publications, and patient education.
  • American Dental Association will provide appropriate scientific and clinical expertise to fully assess and respond to antibiotic healthcare issues, offer continuing education courses at profession meetings, and provide systematic reviews and current scientific information on the proper use of antibiotics in online resources.
  • American Health Care Association and the National Center for Assisted Living will incorporate antibiotic stewardship into its national quality initiative to reduce hospitalizations from skilled nursing care centers (SNCCs) and assisted living communities; promote the CDC’s NHSN reporting program for urinary tract infections to its membership; conduct training sessions at its national and state meetings on antibiotic stewardship and the role SNCC staff play in working with physicians on these goals; participate in planning and implementation calls with CDC staff on infections in SNCC settings that are related to antibiotic stewardship; and partner with other associations to promote better antibiotic stewardship.

  • American Hospital Association will, addition to continuing current collaborations with CDC about this issue, work with stakeholders to share the latest information and resources on the appropriate use of antimicrobials through ongoing communications including webinars, online town halls, advisories and through AHA’s web site.
  • American Medical Association will issue a report on antimicrobial stewardship (fall 2015) and host an educational session on Antibiotic Stewardship at AMA’s House of Delegates Interim Meeting.
  • American Society for Microbiology will promote clinical decision support for infected patients and comprehensive antimicrobial stewardship while ensuring connectivity and rapid insights from the microbiology lab to the patient’s bedside.
  • American Osteopathic Association will engage and communicate on antibiotic stewardship with its members and other interested audiences; provide CME pipeline access and education on antibiotic stewardship; and develop a public relations and educational campaign to drive messages on antibiotic stewardship in a coordinated and compelling manner to its audiences which include osteopathic physicians, patients, and the media.

  • American Public Health Association will continue to support funding for antimicrobial resistance activities related to strengthening antibiotic stewardship as outlined in the President’s FY 2016 budget request; continue to share and promote information about antibiotic stewardship through its social media platforms, including Twitter and Facebook, as well as through its monthly member newsletter “Inside Public Health” and its monthly “Legislative Update;” and continue coverage of news related to antibiotic stewardship in its monthly award-winning newspaper The Nation’s Health as well as through APHA’s online news blog Public Health Newswire.
  • American Society for Microbiology will promote clinical decision support for infected patients and comprehensive antimicrobial stewardship while ensuring connectivity and rapid insights from the microbiology lab to the patient’s bedside.
  • American Society of Consultant Pharmacists will educate clinical staff using CDC’s Core Elements of Antibiotic Stewardship for guidance, including tracking and reporting antibiotic prescribing patterns and committing to taking a leadership role in ensuring appropriate dissemination of information.
  • American Society of Health-System Pharmacists will develop standardized pharmacy department antibiotic stewardship programs metrics, which can lead to higher-quality data to help improve outcomes.
  • Anthem will continue antibiotic stewardship programs focused on hospital acquired infection and evaluate appropriate use of antibiotics in acute respiratory tract infections.

AS - G

  • Ascension Health will, in addition to continuing current collaborations with CDC about this issue, establish facility-based antimicrobial stewardship programs in all Ascension hospitals and adopt Core Elements of Hospital Antibiotic Stewardship Programs, submit antibiotic use and resistance data to CDC, plus regularly evaluate facility antibiograms (the result of a laboratory test for the sensitivity of an isolated bacterial strain to different antibiotics).
  • Association for Professionals in Infection Control and Epidemiology, Inc. will promote antibiotic stewardship through clinician education and training (e.g., help healthcare facilities, policymakers and scientific experts better understand antibiotic use and resistance through educational webinars for clinicians and information provided in its practice resources and in-person infection prevention training, educate membership on use of the Antimicrobial Use and Resistance (AUR) module of the National Healthcare Safety Network [NHSN]); policy advocacy; and consumer education through its consumer information network and consumer-friendly infographics.
  • Association of American Medical Colleges (AAMC) will ensure that the nation’s teaching hospitals, medical schools, and future doctors have the necessary information and resources to effectively use and manage antibiotic treatment by facilitating discussion of this topic through educational programming and networking at professional meetings; sharing educational materials through its iCollaborative and MedEdPortal; and encouraging institutions with innovative antibiotic resistant programs to apply for AAMC Innovation Challenge grants in 2015.
  • Association of Public Health Laboratories will strengthen the State Public Health Laboratory System’s ability to perform surveillance for antibiotic resistance, especially for multidrug resistant pathogens; increase the number of public health laboratories testing for antibiotic resistance and explore opportunities for creating Regional Public Health Laboratory Reference Centers and/or centers of excellence; increase public health laboratory engagement in national, state, and local public health AR surveillance efforts; advocate for Antibiotic Resistance Solution Initiative for members and policymakers; evaluate use of Advanced Molecular Detection and other new testing technologies for the surveillance and characterization antibiotic resistant organisms and facilitate technology transfer and implementation; and advocate for an improved regulatory and guidance development process that will allow for expedited updating of antibiotic susceptibility testing devises to ensure that clinicians are receiving the most up-to-date interpretive criteria to guide antibacterial drug selection.
  • Association of State and Territorial Health Officials will convene a partners’ meeting to review current state activities that align with the National Strategy and Action Plan and discuss further opportunities for state public health engagement; continue to convene state health and agricultural officials to discuss areas of collaboration on the issue of antimicrobial resistance and stewardship, including through a One Health framework; collect and share state examples to inform stewardship activities and policies, including the implementation of stewardship activities in human healthcare settings and regional efforts to address resistance across the continuum of care (National Strategy Goal 1, Anticipated Outcome); and support the proposed CDC Antibiotic Resistance Solutions Initiative and State AR Prevention Programs (“Protect Programs”).
  • AstraZeneca will continue to work to collaborate on developing novel and efficient pathways for developing antibiotics. In particular, AstraZeneca is supporting stewardship and selection of the best drug for a given patient by piloting drug development study designs that show how a new antibacterial agents will actually perform in unmet need settings as part of the overall regulatory approach for new antibiotics. See the White House press release for additional information [PDF – 10 pages].
  • BD Diagnostics and CareFusion’s commitments include: Improve diagnosis and treatment by developing a new diagnostic test to rapidly detect Carbapenem Resistant Enterobacteriaceae (CRE), creating a pandemic sentinel system that includes identification of CRE cases to enable timely intervention, and deploying antimicrobial susceptibility tests (AST) to ensure the appropriate use of all available antibiotics; expand electronic surveillance, by assisting health care providers with monitoring and reporting emerging pathogens and antibiotic resistance trends, and supporting public health efforts to identify likely HAIs through electronic surveillance surrogate markers, such as the MedMined® NIM (nosocomial infection marker) and improve tracking of antibiotic use; and reduce HAIs by continuing research and development into skin antiseptics and needleless connectors to reduce the risks of HAIs. See company press release for additional information.
  • BioMerieux will produce a real-time antibiotic surveillance system; collaborate to ensure next-generation sequence-based typing of pathogens to track patterns; create additional high-medical-value multiplex assays combining host resistance markers, pathogen detection and antimicrobial resistance markers to rapidly diagnose (within approximately 1 hour) the cause of an infection to more accurately tailor empiric and definitive therapy; and validate biomarkers that can differentiate bacterial from viral infections in large cohorts to determine best combination of markers in a single rapid diagnostic assay.
  • Brookdale Senior Living Solutions – Commitment to Antibiotic Stewardship [PDF – 1 page]
    Brookdale Senior Living embraces the importance of an infection prevention and control program in each of our 69 skilled nursing communities. This includes an antibiotic stewardship program (ASP), providin g antibiotic use protocols and monitoring to prevent antibiotic resistance. We are committed to the prudent use of antibiotics on behalf of all residents through a sustainable ASP.We take our role in the judicious  use of antibiotic seriously.  Our communities’ executive leadership teams are committed to continued involvement with the antibiotic stewardship goals, policies and monitoring program.  We facilitate communication between the antibiotic stewardship team with our quality and safety initiatives.The Brookdale ASP is a collaborative effort of community leadership, nursing staff, physicians and pharmacists focused on continuous improvement on use of antibiotic agents in an effort to combat the emergence of resistant organisms.  Brookdale realizes the importance of this process as a necessary component of an overall patient/resident safety program.

    This program utilizes the CDC Core Element s of Antibiotic Stewardship for Nursing Homes. Key to this program is the commitment on the part of the organization to actively evaluate the use of antimicrobial agents based on standards for diagnosis, prescribing and appropriate usage, with ongoing assessments of the program’s strong interdisciplinary  approach.

    The CDC is welcome to summarize our commitments and share the summary online and with other organizations upon request.

    Charlie Anderson
    Vice President, Skilled Healthcare Operations

  • Cardinal Health will provide a step-wise, phased approach to antimicrobial stewardship utilizing the CDC’s Core Elements of Hospital Antibiotic Stewardship Programs; provide educational content, training, and coaching content to help hospitals develop and manage their antibiotic stewardship programs; develop enhanced technology to meet the CDC standards for Surveillance for Antimicrobial Use and Antimicrobial Resistance Options; and help all sizes and types of hospitals with various levels of resources to successfully implement and manage antibiotic stewardship programs.
  • Carolinas HealthCare System will, in addition to continuing current collaborations with CDC about this issue, implement antibiotic stewardship programs in all inpatient locations within three years, including requirement of antibiotic use reporting for skilled nursing facilities, and ambulatory care practices over five years, plus incorporate antibiotic indications and appropriate duration of therapy within electronic medical records.
  • Center for Disease Dynamic, Economics & Policy will continue and expand ongoing work in documenting trends in antibiotic resistance and antibiotic consumption in the United States and around the world in humans (ResistanceMap); conduct additional studies that improve understanding of antibiotic use and resistance; extend the Global Antibiotic Resistance Partnership (GARP), a 6-year outreach project in low- and middle-income countries, resulting in national antibiotic resistance strategies in partner countries; and extend modeling studies on effects of vaccines in reducing the demand for antibiotics in low- and middle-income countries.
  • Cepheid will develop and market products to optimize antimicrobial use in patients with gram-negative sepsis, ventilator-associated pneumonia, multiple types of multidrug-resistant bacterial infections, acute bacterial gastroenteritis, and bacterial vaginosis; collaborate directly with pharmaceutical companies to develop rapid diagnostic tests specifically to support clinical trials of new antibiotics that will be effective against multidrug resistant organisms; work with antimicrobial stewardship programs in academic medical centers worldwide to optimize patient management pathways to promote prudent use of antimicrobial agents through the use of rapid point of care molecular diagnostic tests; and work with its academic, industry, and government partners to develop public policy regarding the promotion of antimicrobial stewardship programs.
  • Clinical and Laboratory Standards Institute will be at the forefront of identifying, quantifying, and addressing bacterial resistance to anti-infective agents for humans and animals by providing relevant and timely standards for laboratories and clinicians resulting in improved health care for people and animals.
  • Clorox Healthcare is committed to better understanding the science behind the reservoirs, vehicles, and mode of transmission of infectious pathogens in health care setting. Specific deliverables may include: assembling clinical and industry experts to formulate a broad approach to antibiotic stewardship; working with CDC and clinical experts to help design and coordinate clinical randomized studies to validate alternate means to prevent MDROs; providing products for testing; assisting with rapid diagnostic testing; and helping support educational sessions, infection control training and support, and assessment programs on the best practices around preventing MDROs.
  • Consumers Union/Consumer Reports will publish a three-part series in Consumer Reports magazine dedicated to antibiotic resistance with each part devoted to a different aspect: (1) drugs, (2) hospitals, (3) food system; to be published in second half of 2015.
  • Council of State and Territorial Epidemiologists will continue working to establish more effective relationships among state and other health agencies; providing technical advice and assistance to partner organizations and to federal public health agencies such as the CDC; and supporting effective public health surveillance and good epidemiologic practice through training, capacity development, and peer consultation.
  • Diatherix Laboratories is committed to actively promote principles of good antibiotic stewardship and to expand availability and use of diagnostics to identify infectious pathogens, improve treatment of antibiotic resistant infections, enhance infection control, and facilitate outbreak detection and response in healthcare and community settings. In addition to other activities, Diatherix is committed to providing education symposia in the U.S. on an annual basis. In November 2016, Diatherix was the primary presenting sponsor of ABX CROSSROADS: A National Dialogue on Antimicrobial Stewardship targeting audiences from the acute and post-acute care settings such as health system executives, physicians, infection control specialists, and pharmacists.
  • Federation of American Hospitals will work with the White House and CDC to ensure that member hospitals have the latest information to enable their ongoing work to join in partnership to reduce the misuse and overuse of antibiotics; and facilitate discussions and educational programming through communication tools including its website, national meetings, and the FAH policy blog.
  • Galderma Laboratories will continue its commitment to antibiotic stewardship within dermatology by taking the necessary steps to cease the commercialization of topical antibiotics through all of its national subsidiaries, is dedicated to bringing new antibiotic-free treatment options to market, make safe and effective acne treatment options that are alternatives to antibiotics, and will participate in CDC’s Get Smart About Antibiotics Weeks and in other strategic partnerships.
  • Genesis HealthCare will disseminate best practices from ten centers currently enrolled in a quality improvement project focused on reducing urinary tract infections and unnecessary antibiotic use, plus assign regional clinicians to evaluate resistance patterns within their region and regularly report to leadership for company-wide education and updates to staff and will provide resistance and antibiogram data to be produced, shared, and acted upon with individual lab providers at every center.
  • George Washington University Milken School of Public Health will announce the launch of the Antibiotic Resistance Action Center, which will devise innovative solutions to combat antibiotic resistance, uniting cutting-edge science, creative communications, and evidence-based policies that will preserve the utility of antibiotics.
  • GOJO will conduct collaborative studies with the CDC, other government agencies and public health organizations to advance the science of hand hygiene and infection prevention; support CDC’s Get Smart programs with media efforts targeting healthcare and public health leaders, educators, and parents; and launch a “100 Million Days of Learning” program with school systems to reduce student absenteeism through hand hygiene.
  • GenMark Diagnostics We are committed to marketing and continued development of products that rapidly distinguish between viral and bacterial infections and detect antimicrobial resistant organisms to aid in guiding clinical decisions to optimize use of appropriate antimicrobials and limit the use of broad spectrum or last line antimicrobials. Additionally, we will sponsor studies and support peer-reviewed clinical publications that demonstrate the benefits of rapid detection and antimicrobial stewardship, and collaborate and support industry and society initiatives that promote the judicious use of antimicrobials through rapid molecular diagnostics.

H - O

  • Henry Ford Health System will ensure appropriate antimicrobial use throughout its health system. By 2017, the health system will implement the CDC core elements for antibiotic stewardship programs and aim to make the following improvements: implementing a 72-hour “time-out” for intravenous antimicrobials; implementing a “smart stop date” in EMR systems reflecting best available evidence on duration of therapy; participating in NHSN reporting of antimicrobial utilization; integrating antimicrobial stewardship goals in outpatient prescribing for patients seen in its emergency departments and clinics; and implementing transition of care programs to improve the quality and safety of Outpatient Parenteral Antimicrobial Therapy across the health system.
  • Hospital Corporation of America will, in addition to continuing current collaborations with CDC about this issue, develop and implement new clinical decision support and real-time antibiogram tracking to rapidly respond to lab results, catch bug-drug mismatches, implement strategy to prevent health-care associated infections in adult intensive care unit patients, and strengthen national efforts to identify and report cases of antibiotic resistance.
  • The Illinois Department of Public Health is committed to maintaining an advisory council to inform antibiotic stewardship efforts; annually host a statewide summit to convene healthcare professionals to share stewardship implementation strategies and best practices; raise public awareness of antibiotic use and misuse, and promote appropriate prescribing in outpatient settings through the Precious Drugs and Scary Bugs campaign; participate in Get Smart Week, engaging schools and workplaces; increase healthcare facility reporting to the NHSN AUR module; and track resistant infections and stewardship across healthcare settings to guide development of improvement initiatives and policies.
  • IMS Health will continue, under existing terms, its longstanding data support and research collaboration with CDC that will involve the continued tracking of the use of antimicrobial medicines and corresponding analysis of trends, patterns, and variations that involve prescribers, payers, and patients; and explore the application of other IMS assets and tools toward better understanding and addressing issues around antibiotic resistance.
  • Infectious Diseases Society of America will, in addition to continuing current collaborations with CDC about this issue, lead broad and robust stakeholder advocacy in support of antibiotic stewardship, implementation of stewardship programs in inpatient settings, measurement, and evaluation of stewardship efforts; promote research and development and appropriate use of diagnostics to guide stewardship; and promote stewardship in the outpatient setting and in the agricultural setting.
  • Intermountain Healthcare will, in addition to continuing current collaborations with CDC about this issue, reduce inappropriate outpatient antibiotic use for upper respiratory conditions by 50% by 2020, ensure all Intermountain Healthcare acute care hospitals have antimicrobial stewardship programs by the end of 2017, plus support telemedicine efforts to extend infectious disease expertise to rural healthcare settings.
  • International College of Dentists (ICD) has established a partnership with CDC’s Get Smart About Antibiotics program to disseminate critical information on antibiotic resistance and appropriate antibiotic use in dentistry and medicine to ICD Fellows worldwide. This information can be used in their practices, taught in education institutions, and shared with their communities. See PDF of commitment letter for more information [PDF – 382].
  • Johns Hopkins Medicine will have Antibiotic Stewardship Programs (ASP) in all of its hospitals over the next two years by implementing and sustaining activities that include all sites reporting data to the NHSN AUR module and agreeing upon, disseminating Johns Hopkins Medicine guidelines for antibiotic use, and developing, executing, and reporting targeted interventions to improve antibiotic prescribing.
  • Johnson & Johnson will monitor the development of resistance to its new TB drug; contribute courses of the drug to USAID’s global system-strengthening, data collection, and medical education efforts; with USAID and partners, engage with National TB programs to build systems, infrastructure, and competencies; and through collaboration with academic institutions, physical groups, and non-governmental organizations, continue to share content, develop materials, commission tailor-made training sessions, organize regional and local symposia, and develop web-based knowledge platforms.
  • Kaiser Permanente will, in addition to continuing current collaborations with CDC about this issue, support antibiotic stewardship programs and guide prescribing practices for antimicrobials at every Kaiser Medical Center with electronic alerts, order sets, etc.
  • Medscape/WebMD will continue to cover the topic of antibiotic resistance and stewardship extensively with news, expert commentaries, and Questions & Answers with experts and organizations.
  • Melinta is committed to research efforts to discover and develop new classes of antibiotics to combat resistant bacterial pathogens, and providing physician and patient education on appropriate use of its antibiotics that may receive FDA approval in the coming years.
  • NACDS Foundation is committed to supporting POC testing and patient care research that will evaluate the impact of its innovative neighborhood pharmacy-antibiotic stewardship model; disseminating the knowledge garnered through this research in an effort to contribute towards sustainable solutions to reduce antibiotic resistance; and  working collaboratively with CDC and other partners to create opportunities for CPA-based outpatient, neighborhood pharmacy stewardship programs in all U.S. states and territories.
  • Nanosphere will advance the diagnostic technology that enables rapid detection of and response to drug-resistance bacteria; support the generation of additional peer-reviewed clinical evidence to demonstrate the clinical and economic benefits of antimicrobial stewardship; and support the development of cross-functional best practices within healthcare settings to ensure that faster and more accurate diagnostics lead to optimal patient treatment and appropriate antibiotic usage.
  • National Association of Chain Drug Stores will integrate stewardship principles into existing programs that provide free or reduced price antibiotics to patients; will develop a new educational model on “using point of care tests in pharmacies to promote antimicrobial stewardship and combat antimicrobial resistance;” and will aim to examine the literature supporting outpatient antimicrobial stewardship programs, develop the requisite infrastructure for outpatient clinic and pharmacy stewardship programs, and convene member forums to disseminate the knowledge and showcase implementation of neighborhood stewardship programs.
  • National Association of County and City Health Officials will sustain or expand existing demonstration projects that enable local health departments to engage with local healthcare partners and other stakeholders to improve antibiotic stewardship and address resistance in order to increase activities in: local health department engagement and roles in antibiotic stewardship efforts, characterization of current antibiotic use and stewardship in healthcare settings, understanding of facilitators and barriers to improving stewardship, identification and promotion of existing or new strategies that effectively initiate or expand stewardship, and the evidence base of the need and opportunities for local health departments to continue improving stewardship in partnership with local healthcare partners and other stakeholders.
  • National Association of Directors of Nursing Administration in Long Term Care will collaborate with other associations to conduct training and get its antibiotic stewardship message out to families, caregivers, and loved ones through venues like webinars, seminars, printed materials, and social media; conduct training at annual and state meetings;  continue development of an Infection Prevention Certification, which has questions about antibiotic stewardship included in the exam, for nurses and then ombudsmen, social workers, dieticians, and administrators; and make members aware of any antibiotic stewardship programs being conducted by other groups.
  • National Consumer Voice for Quality Long-Term Care will educate the 8,500 long-term care ombudsmen across the U.S. in the new understanding of infections and antibiotic stewardship so the ombudsmen can be fully informed and helpful to residents and families when there are questions or misunderstanding about decisions to test or not test for infections and to prescribe or not use antibiotics. See PDF for complete panel remarks.
  • National Quality Forum will work with federal agencies and private-sector stakeholders to encourage the development and submission of performance measures that can be used in quality improvement and accountability programs for benchmarking and improving appropriate antibiotic utilization through better stewardship; work to expedite the process so that, if endorsed, measures are positioned for rapid implementation in public and private programs; encourage and support the use of antibiotic resistance and utilization measures through its diverse membership and ongoing measurement selection activities; promote a shared agenda for progress that is aligned with the National Action Plan to Combat Antibiotic-Resistant Bacteria; and offer education and engagement opportunities to its members about antibiotic stewardship.
  • New Jersey Hospital Association (NJHA)’s Institute for Quality and Patient Safety and the New Jersey Hospital Improvement Innovation Network (NJHIN) have created a three-year Antimicrobial Stewardship Learning and Action Collaborative. The cooperative will promote appropriate antibiotic use by implementing CDC’s seven core elements throughout the acute care and post-acute care setting. See pdf commitment letter for more information [PDF – 78KB].
  • Nile’s Project will continue to share lessons learned, spread words of hope that infectious deaths caused by MRSA and other HAIs can be prevented through simple practices like attention to hygiene and education of prevention techniques it can share to reduce infection rates, and use its music industry background and contacts to provide awareness concerts, school and community patient safety workshops, tradeshows, and distribution of patient safety collateral in English and Spanish to educate the public when and wherever possible.
  • OpGen will use rapid tools to enable healthcare facilities and public health organizations identify, characterize, and track multi-drug resistant organism threats and infections; help form a public health surveillance network that identifies, tracks, and trends antibiotic resistance; and genetically characterize the antibiotic resistant bacteria to guide future drug development and optimal prescriptions of currently available antibiotics.

P - Z

  • Palomar Health [PDF – 1 page] will continue to serve as a leader throughout San Diego County and the state of California in supporting appropriate use for antibiotics.
  • PDI Healthcare will, in addition to other activities, incorporate CDC’s antimicrobial resistance messaging into communications materials, create a module that would be required of all customer-facing associates on the core principles of antimicrobial resistance; and support resistance studies for product approval and registration protocols to mitigate potential resistance created by antimicrobial agents; and create  accredited continuing education presentations for healthcare professionals.
  • Pediatric Infectious Disease Society will, in addition to continuing current collaborations with CDC about this issue, assure that adult-based hospitals that care for children have effective Antimicrobial Stewardship for their pediatric patients, plus support clinical studies to optimize antibiotic use in children.
  • Peggy Lillis Foundation will bring patient and lay perspectives to antibiotic stewardship policies and research through collaboration; educate the broad public on the immediate and long-term harm caused by over- and misuse of antibiotic through a range of media; collaborate with industry partners to develop and drive consumer education campaigns on antibiotic over- and minuse as a key driver of Clostridium difficile infections; train 25 state-based advocates to provide local education on antibiotic resistance and stewardship; support local advocacy to increase public reporting of resistant infection across the health care spectrum; and build citizen support for legislation related to stewardship and innovation.
  • Premier Healthcare Alliance will be setting a measurable goal for this collaborative and sharing the goal at the Forum. In addition to assisting hospitals with implementing all aspects of an antimicrobial stewardship program, Premier will also be launching specific technology tools and collaboratives that target specific antimicrobial misuse issues.
  • Procter & Gamble will provide knowledge and perspective on the use of personal hygiene, home hygiene, and cleaning products and their utility in reducing infections and antibiotic use, as well as knowledge of new technical approaches that may enable reduction of antibiotic use, such as probiotics, prebiotics, and phage.
  • Providence St. Joseph Health [2 pages] By the end of 2017, Providence St. Joseph’s Health will have ASP work in progress in all care settings, and will fully implement the CDC core elements of an ASP in all acute care and skilled nursing facilities, including the following three key improvements: resources sufficient to develop, support and maintain an ASP throughout the system; evidence-based clinical practice guidelines and electronic health record pathways for the most frequent infections; as well as data and education on critical elements of the ASP, including individual prescribing patterns and guideline adherence.
  • PYA incorporates the CDC’s antimicrobial resistance messaging into all antibiotic stewardship advisory materials and will continue to assist hospitals, long term care facilities, clinics, and private practices in the establishment, evaluation, integration, and measurement of programs to achieve effectiveness. In doing so, PYA aims to promote rapid diagnosis to guide stewardship efforts, request programs to submit antibiotic use and resistance data to CDC, analyze antibiograms to determine individual community best practices, and assist in providing education to the public and providers in the community in efforts to help decrease antibiotic resistance.
  • Quality Insights Quality Innovation Network is committed to promoting and implementing antibiotic stewardship. Under contract with the Centers for Medicare & Medicaid Services, Quality Insights is initiating a new project:Combatting Antibiotic Resistant Bacteria through Antibiotic Stewardship in Communities. Our goal is to spread antibiotic stewardship among recruited outpatient settings at the point of care, where antibiotics are being prescribed. We are working with outpatient settings to help them incorporate the CDC Core Elements of Outpatient Antibiotic Stewardship. See Quality Insights Quality Innovation NetworK [PDF – 94 KB] for the complete commitment letter.
  • Reckitt-Benckiser (RB) will explore supporting antibiotic stewardship through various avenues, which could include: public education through messages placed on the LYSOL & MUCINEX websites and Facebook pages; messages placed at point-of sale in retail; print ads and messages attached to TV commercials; RB-initiated research and/or review papers highlighting how prevention of infections or proper treatment of symptoms can impact antibiotic resistance by reducing use; use of the RB-sponsored Global Hygiene Council to promote key messages about preventing antibiotic resistance; and use of the RB-sponsored GRIP organization to promote key messages about preventing antibiotic resistance.
  • Safe Care Campaign will create sustainable and continual internet education for professional caregivers through the campaign’s website; produce Public Service Ads (video PSAs) to educate the general public about antibiotic resistance; be willing to actively participate in meetings and committees going forward; and work with other organizations in order to coordinate White House Forum goals and disseminate information.
  • Sanofi Pasteur will continue development of new antibiotics, biologics, and vaccines for the treatment and prevention of disease in humans and animals; is open to participating in efforts to address antimicrobial resistance, including consumer and provider education and epidemiologic studies to improve or support use of vaccines; and would provide technical and medical review of data and approaches.
  • Shionogi will collaborate on the development of approval pathways that will enable clinical studies of therapies specifically treating multi-drug resistant pathogens, as demonstrated through multiple engagements with regulatory authorities.
  • Society for Healthcare Epidemiology of America will, in addition to continuing current collaborations with CDC about this issue, develop and deploy multi-healthcare setting education and training for healthcare teams on antibiotic stewardship; develop implementation guidance for stewardship programs in healthcare settings; lead stakeholder discussions on coordinated human stewardship efforts;  and assist CDC to promote national and regional AR surveillance efforts, including regional lab network.
  • Society of Hospital Medicine will, in addition to continuing current collaborations with CDC about this issue, create a Society of Hospital Medicine Behavior Change (Awareness) Campaign to enhance hospitalists’ awareness of key antibiotic use best practices and ask them to formally commit to at least two behavior changes to reduce inappropriate antimicrobial use and reduce antimicrobial resistance.
  • Society of Infectious Diseases Pharmacists will expand their Antimicrobial Stewardship Certificate Program for Pharmacists.
  • Streck has identified an important goal in which they have meaningfully invested. It will be to reduce inappropriate antibiotic use, to identify and curtail the emergence and propagation of drug-resistant organisms and thereby reduce the spread of infection, and to support increased educational training by participating in programs such as the “Get Smart” program. As part of the initiative, Streck has and will continue to establish collaborations and partnerships with experts in the academic, agricultural, clinical, and commercial sectors to facilitate the development, market, and sale of products that quickly and accurately identify drug-resistant infections.
  • The Evangelical Lutheran Good Samaritan Society will partner with CDC to explore development of robust reporting mechanisms for infections and antibiotic prescribing in post-acute and residential senior care centers, provide educational support for residents, families, staff and provider partners highlighting quality and safety measures key to understanding and supporting prescribing of antibiotics and care practices to minimize harm from medication adverse events, overuse of antibiotics and preventable infections, and create and implement a comprehensive clinical guideline spanning all of the Society’s service lines.
  • The Joint Commission will include stewardship as part of onsite surveys.
  • The Pew Charitable Trusts will combat antibiotic resistance by investing in research and supporting policy development in three main areas: actionable national goals for antibiotic use reduction, by partnering with CDC and facilitating data analysis needed to support national reduction goals; stewardship in all settings, by conducting and commissioning research, hiring technical experts, and coordinating other stakeholders to support the responsible use of antibiotics in every setting where they are used; and spurring drug development, by working with antibiotic discovery experts to identify the key scientific challenges that pose obstacles to discovery efforts and develop a roadmap to overcome them.
  • Theravance BioPharma propose, among other activities, focusing on education for healthcare providers to ensure physicians have the information to support appropriate use and conservation of antibiotics; funding Investigator Initiated Research in the stewardship space; and conducting advisory boards and directly consulting with healthcare professionals to gather additional insight on ways to improve company support for antimicrobial stewardship programs.
  • TridentUSA Health Services will expand education and lab services, including expansion of genetic testing for C. difficile and facility-specific antibiogram availability.
  • Trust for America’s Health (TFAH) will continue to call attention to the problem of antimicrobial resistance through future reports, press releases, and social media and continue to recommend ways to strengthen antibiotic stewardship in TFAH publications; continue to support stewardship of antibiotics in medicine and animal agriculture through federal advocacy, including through legislation and regulatory policy; advocate for broadening and strengthening of antibiotic stewardship programs in human medicine and agriculture through policies and funding of CDC, FDA, and CMS; advocate for antibiotic stewardship through healthcare quality measures, healthcare accreditation, electronic health records and other mechanisms; and advocate for full implementation of the National Strategy for Combating Antibiotic-Resistant Bacteria.
  • UF Health Shands Hospital has a long-standing history of leadership support for antimicrobial stewardship since the formulation of the Anti-Infective subcommittee in 2009. Pediatric pharmacists and pediatric infectious disease doctors are part of the Anti-Infective Committee that formulates protocols and policies for microbiology testing and appropriate antimicrobial use. UF Health Shands Hospital continues to demonstrate leadership commitment, accountability, drug expertise, advocacy, tracking, reporting and education in the pursuit of improving antimicrobial utilization.
  • Vermont Oxford Network, in collaboration with CDC, will lead the Internet-based Newborn Improvement Collaborative for Quality (iNICQ) to provide hospitals, health systems, and states with the resources and guidance to standardize policies, implement evidence-based practices, and institute antibiotic stewardship programs with an aim for a 25% reduction in the use of antibiotics for newborns and mothers. The quality improvement collaborative engages teams from newborn nurseries, birth centers, and NICUs around the world to reduce unnecessary antibiotic use during the perinatal period by using proven quality improvement methods and focusing on rapid-cycle adoption of published guidelines from the AAP and ACOG.
  • VHA will enhance members’ ability to collect and mine diverse patient data; develop a reproducible roadmap for best practices in antibiotic stewardship and infection prevention; facilitate collaboration among hospitals and health systems to identify, share, and promote best practices; provide online resource guides; host webinars on reducing HAIs; hold regional antimicrobial stewardship and infection prevention meetings; host presentations/discussions with key thought leaders; influence members to submit data to CDC’s NHSN AUR; disseminate key information to members; and work real-time with regional pharmacy networks comprised of550 hospitals nationally.
  • Walgreens/Take Care Clinics will focus on: patient awareness and knowledge of appropriate antibiotic use, by making information available in-store and through its omni-channel approach; Walgreens practitioner awareness, by providing pharmacists, pharmacy technicians and its healthcare clinic nurse practitioners and physician assistants with the most up to date knowledge and information to support patient awareness programs, as well as continued focus of Healthcare Clinic nurse practitioners and physician assistants on prescribing protocol; and exploring partnering with the CDC on protocol prescribing for antibiotics.
  • What to Expect Foundation will add/revise information regarding appropriate antibiotic use in the “What to Expect” book series, as well as on the “What to Expect” website, plus share updated information with parents through “What to Expect” blogs, social media, and other online content.